Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus in MRSA Positive Ulcers

NCT00790608 is registered in ClinicalTrials.gov with Nitric BioTherapeutics, Inc as lead sponsor.

NCT NCT00790608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00790608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus in MRSA Positive Ulcers
Lead sponsor
Nitric BioTherapeutics, Inc
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2009
Completion date
August 31, 2011
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methicillin-resistant staphylococcus aureus infection, skin ulcers